High quality Epoprostenol Sodium/ Prostacyclin sodium salt CAS NO.61849-14-7
- FOB Price: USD: 1.00-1.00 /Metric Ton Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
1(1-10)Metric Ton
- Product Details
Keywords
- Prostacyclin sodium salt
- 61849-14-7
- Epoprostenol Sodium
Quick Details
- ProName: High quality Epoprostenol Sodium/ Pros...
- CasNo: 61849-14-7
- Molecular Formula: 61849-14-7
- Appearance: White powder
- Application: pharmaceutical intermediates
- DeliveryTime: WIthin 2 days
- PackAge: 25KG/DRUM
- Port: Qingdao Port
- ProductionCapacity: 3000 Metric Ton/Month
- Purity: 99%
- Storage: Store in dry dark and ventilated place
- Transportation: By express,By Air or by sea
- LimitNum: 1 Kilogram
- Moisture Content: NA
- Impurity: NA
- Email: info@sigmachemical.com.cn
Superiority
Details
High quality 61849-14-7 with best price
Prouduct name: PROSTACYCLIN SODIUM SALT
CAS: 61849-14-7
Appearance: White solid
Purity: 99.0%min
Prouduct name: PROSTACYCLIN SODIUM SALT
CAS: 61849-14-7
Appearance: White solid
Purity: 99.0%min
Certifation of High quality 61849-14-7 with best price
Product Name: | PROSTACYCLIN SODIUM SALT |
Synonyms: | EPOPROSTENOL;EPOPROSTENOL SODIUM;EPOPROSTENOL SODIUM SALT;(5-Z)-9-DEOXY-6,9ALPHA-EPOXY-PGF1ALPHA, SODIUM SALT;[5Z,9ALPHA,11ALPHA,13E,15S]-6,9-EPOXY-11,15-DIHYDROXYPROSTA-5,13-DIEN-1-OIC ACID SODIUM SALT;6,9ALPHA-EPOXY-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID, SODIUM SALT;PROSTACYCLINE SODIUM SALT;PROSTACYCLIN SODIUM SALT |
CAS: | 61849-14-7 |
MF: | C20H31NaO5 |
MW: | 374.45 |
EINECS: | 234-237-8 |
Product Categories: | Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals |
Mol File: | 61849-14-7.mol |
More inforemation of High quality 61849-14-7 with best price
Storage:It should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Application of High quality 61849-14-7 with best price
Used as a pharmaceutical intermediates.
Mainly for the treatment of certain cardiovascular diseases (such as cardiopulmonary bypass, hemodialysis, etc.) as anti-glues to prevent hypercoagulable state